FactSet Research Systems (FDS) recently reaffirmed its regular shareholder return program, with the Board approving a quarterly cash dividend of US$1.16 per share, payable on 17 September 2026 to holders of record on 31 August.

The dividend affirmation arrives after a strong recent rebound in FactSet Research Systems’ share price, with a 30 day share price return of 12.86% and a 90 day return of 33.36%. However, longer term total shareholder returns over one, three and five years remain negative, suggesting momentum has picked up recently while longer term holders have seen weaker outcomes.

If this dividend update has you reassessing your watchlist, it could be a good moment to look beyond a single stock and check out 20 top founder-led companies

FactSet Research Systems has moved sharply in recent months while longer term returns remain under pressure. Is this rebound pointing to a business that now looks mispriced, or just a sentiment swing that got ahead of itself?

Most Popular Narrative: 11.1% Overvalued

FactSet Research Systems closed at $283.49, while the most followed narrative puts fair value at $255.06. That gap rests on a detailed set of growth and margin assumptions.

FactSet is integrating new acquisitions like Irwin and LiquidityBook, adding immediate cross-sell opportunities and expanding services across buy-side and banking workflows, which will support revenue growth. The launch of new GenAI products, including Pitch Creator and conversational API, is expected to provide additional services that drive adoption and increase ASV growth, positively impacting future revenue.

Curious what kind of revenue runway and profit profile the narrative needs to justify that fair value gap. The answer leans heavily on steady top line growth, higher margins and a meaningfully lower future earnings multiple than many peers.

Result: Fair Value of $255.06 (OVERVALUED)

However, the FactSet Research Systems narrative still faces clear pressure from rising technology expenses, as well as ongoing cost cuts at asset managers and banks that could restrain growth assumptions.

Another View on FactSet Research Systems Valuation

Analysts currently view FactSet Research Systems as 11.1% overvalued at $283.49 versus a $255.06 fair value, based on future earnings assumptions. Our DCF model points in a different direction, with a fair value estimate of $385.98, which suggests the stock is trading at a discount. Which framework aligns better with your own expectations around growth, margins, and required returns?

Next Steps

With FactSet Research Systems pulling in different signals on price, value, and growth expectations, it makes sense to move quickly and test the numbers against your own assumptions. To weigh the upside potential against the issues investors are worried about, start with the 4 key rewards and 1 important warning sign.

Looking for more investment ideas beyond FactSet Research Systems?

If you only focus on FactSet Research Systems, you could miss other opportunities that fit your style better. Use the Simply Wall St screener to widen your options.

• Target dependable income by checking out 10 dividend fortresses that combine higher yields with a focus on stability.
• Hunt for potential value opportunities through 50 high quality undervalued stocks that pair solid fundamentals with prices that sit below their estimated worth.
• Prioritise capital protection first by reviewing 83 resilient stocks with low risk scores that show stronger resilience on key risk metrics.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.